Drug Profile
Oprelvekin biosimilar - Xiamen Amoytop Biotech
Alternative Names: Interleukin-11 - Xiamen Amoytop Biotech; TopmegaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Xiamen Amoytop Biotech
- Class Antineoplastics; Chemoprotectants; Interleukins; Recombinant proteins
- Mechanism of Action Immunostimulants; Interleukin 11 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Thrombocytopenia